INFINITIES TECH (01961) may delay the publication of its 2025 annual performance. Suspension of trading is expected to begin on April 1st.
Toro Technology (01961) announced that the company is expected to be unable to publish its 2025 annual results by March 31, 2026, as required by listing rules. The company will also postpone the convening of a board meeting to consider and approve the 2025 business and its publication. The board expects the trading of the company's shares to be suspended from 9:00 am on April 1, 2026 (Wednesday) to await the publication of the 2025 annual results.
INFINITIES TECH (01961) announces that it is expected the company will not be able to publish its 2025 annual results before March 31, 2026, as required by listing rules. The company will also postpone the convening of the board meeting, including to consider and approve the 2025 business and its publication. The board of directors expects the company's shares to be suspended from trading from 9:00 am on Wednesday, April 1, 2026, pending the publication of the 2025 annual results.
Related Articles

TIANJINPORT DEV (03382) releases annual performance results, with a shareholder net profit of HK$667 million, a decrease of 3.4% year-on-year.

REMEGEN (09995) released its annual performance, with a net profit attributable to shareholders of 710 million yuan, turning losses into profits year-on-year.

PROSPER FUTURE (01259) announced its performance for the year 2025, with a net loss attributable to shareholders of approximately HK$73.209 million, representing an increase of 36.26% year-on-year.
TIANJINPORT DEV (03382) releases annual performance results, with a shareholder net profit of HK$667 million, a decrease of 3.4% year-on-year.

REMEGEN (09995) released its annual performance, with a net profit attributable to shareholders of 710 million yuan, turning losses into profits year-on-year.

PROSPER FUTURE (01259) announced its performance for the year 2025, with a net loss attributable to shareholders of approximately HK$73.209 million, representing an increase of 36.26% year-on-year.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


